No evidence of XMRV in prostate cancer cohorts in the Midwestern United States

Retrovirology

Volumn 8, Issue , 2011, Pages

  Sakuma, Toshie ^a   Hué, Stéphane ^b   Squillace, Karen A ^a   Tonne, Jason M ^a   Blackburn, Patrick R ^a   Ohmine, Seiga ^a   Thatava, Tayaramma ^a   Towers, Greg J ^b   Ikeda, Yasuhiro ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS DNA; XENOTROPIC MULV RELATED VIRUS ANTIBODY; 2 5A DEPENDENT RIBONUCLEASE; 2-5A-DEPENDENT RIBONUCLEASE; RIBONUCLEASE;

ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; CANCER GRADING; CANCER TISSUE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; GENE; GENE AMPLIFICATION; GENE MUTATION; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; PROSTATE EPITHELIUM; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS INFECTION; RNASEL GENE; SEQUENCE HOMOLOGY; TUMOR IMMUNITY; UNITED STATES; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS LOAD; VIRUS NEUTRALIZATION; XENOTROPIC MULV RELATED VIRUS INFECTION; ANIMAL; BLOOD; CASE CONTROL STUDY; CELL LINE; CLASSIFICATION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR GENETICS; MOUSE; MUTATION; PHYLOGENY; PROSTATE; PROSTATE TUMOR; VIROLOGY; XENOTROPIC MULV RELATED VIRUS;

MUS; XENOTROPIC MURINE LEUKEMIA VIRUS;

AGED; ANIMALS; ANTIGENS, VIRAL; CASE-CONTROL STUDIES; CELL LINE; COHORT STUDIES; ENDORIBONUCLEASES; HUMANS; MALE; MICE; MIDDLE AGED; MIDWESTERN UNITED STATES; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; PROSTATE; PROSTATIC NEOPLASMS; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

EID: 79953082241     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-8-23     Document Type: Article

References (32)

1. Simard J, Dumont M, Soucy P, Labrie F. Perspective: prostate cancer susceptibility genes. Endocrinology 2002, 143:2029-2040. 10.1210/en.143.6.2029, 12021166.
2. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 2002, 32:581-583. 10.1038/ng1021, 12415269.
3. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, et al. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006, 2:e25. 10.1371/journal.ppat.0020025, 1434790, 16609730.
4. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, Derisi JL, Chow SA, Silverman RH. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA 2007, 104:1655-1660. 10.1073/pnas.0610291104, 1776164, 17234809.
5. Baliji S, Liu Q, Kozak CA. Common inbred strains of the laboratory mouse that are susceptible to infection by mouse xenotropic gammaretroviruses and the human-derived retrovirus XMRV. J Virol 84:12841-12849. 10.1128/JVI.01863-10, 20943975.
6. Hue S, Gray ER, Gall A, Katzourakis A, Tan CP, Houldcroft CJ, McLaren S, Pillay D, Futreal A, Garson JA, et al. Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 2010, 7:111. 10.1186/1742-4690-7-111, 3018392, 21171979.
7. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci USA 2009, 106:16351-16356. 10.1073/pnas.0906922106, 2739868, 19805305.
8. Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, Johnson NA, Bhosle SM, Liotta D, Hunter E, Marshall FF, et al. XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 2010, 75:755-761. 10.1016/j.urology.2010.01.038, 20371060.
9. Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, De Marzo AM, Rein A. XMRV: a new virus in prostate cancer?. Cancer Res 2010, 70:10028-10033. 10.1158/0008-5472.CAN-10-2837, 20966126.
10. Verhaegh GW, de Jong AS, Smit FP, Jannink SA, Melchers WJ, Schalken JA. Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in dutch prostate cancer patients. Prostate 2010, 71(4):415-20. Epub 2010 Sep 28, 10.1002/pros.21255, 20878949.
11. Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, Denner J, Miller K, Kurth R, Bannert N. Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 2009, 6:92. 10.1186/1742-4690-6-92, 2770519, 19835577.
12. Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, Aepfelbacher M, Schlomm T. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 2008, 43:277-283. 10.1016/j.jcv.2008.04.016, 18823818.
13. Sakuma R, Sakuma T, Ohmine S, Silverman RH, Ikeda Y. Xenotropic murine leukemia virus-related virus is susceptible to AZT. Virology 2010, 397:1-6. 10.1016/j.virol.2009.11.013, 2821880, 19959199.
14. Sakuma T, Tonne JM, Squillace KA, Ohmine S, Thatava T, Peng KW, Barry MA, Ikeda Y. Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari. J Virol 2011, 85:1205-1213. 10.1128/JVI.00886-10, 21084477.
15. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009, 326:585-589. 10.1126/science.1179052, 19815723.
16. Lo SC, Pripuzova N, Li B, Komaroff AL, Hung GC, Wang R, Alter HJ. Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci USA 2010, 107:15874-15879. 10.1073/pnas.1006901107, 2936598, 20798047.
17. Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 2006, 22:2688-2690. 10.1093/bioinformatics/btl446, 16928733.
18. Malet I, Belnard M, Agut H, Cahour A. From RNA to quasispecies: a DNA polymerase with proofreading activity is highly recommended for accurate assessment of viral diversity. J Virol Methods 2003, 109:161-170. 10.1016/S0166-0934(03)00067-3, 12711059.
19. Bracho MA, Moya A, Barrio E. Contribution of Taq polymerase-induced errors to the estimation of RNA virus diversity. J Gen Virol 1998, 79(Pt 12):2921-2928.
20. Cline J, Braman JC, Hogrefe HH. PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. Nucleic Acids Res 1996, 24:3546-3551. 10.1093/nar/24.18.3546, 146123, 8836181.
21. Switzer WM, Jia H, Hohn O, Zheng H, Tang S, Shankar A, Bannert N, Simmons G, Hendry RM, Falkenberg VR, et al. Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology 2010, 7:57. 10.1186/1742-4690-7-57, 2908559, 20594299.
22. Oakes B, Tai AK, Cingoz O, Henefield MH, Levine S, Coffin JM, Huber BT. Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology 2010, 7:109. 10.1186/1742-4690-7-109, 3022687, 21171973.
23. Robinson MJ, Erlwein OW, Kaye S, Weber J, Cingoz O, Patel A, Walker MM, Kim WJ, Uiprasertkul M, Coffin JM, McClure MO. Mouse DNA contamination in human tissue tested for XMRV. Retrovirology 2010, 7:108. 10.1186/1742-4690-7-108, 3019155, 21171966.
24. Sato E, Furuta RA, Miyazawa T. An Endogenous Murine Leukemia Viral Genome Contaminant in a Commercial RT-PCR Kit is Amplified Using Standard Primers for XMRV. Retrovirology 2010, 7:110. 10.1186/1742-4690-7-110, 3024226, 21171978.
25. Kim S, Kim N, Dong B, Boren D, Lee SA, Das Gupta J, Gaughan C, Klein EA, Lee C, Silverman RH, Chow SA. Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol 2008, 82:9964-9977. 10.1128/JVI.01299-08, 2566297, 18684813.
26. Tomonaga K, Coffin JM. Structures of endogenous nonecotropic murine leukemia virus (MLV) long terminal repeats in wild mice: implication for evolution of MLVs. J Virol 1999, 73:4327-4340. 104214, 10196331.
27. Qiu X, Swanson P, Luk KC, Tu B, Villinger F, Das Gupta J, Silverman RH, Klein EA, Devare S, Schochetman G, Hackett J. Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies. Retrovirology 2010, 7:68. 2931451, 20716359.
28. Groom HC, Boucherit VC, Makinson K, Randal E, Baptista S, Hagan S, Gow JW, Mattes FM, Breuer J, Kerr JR, et al. Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 2010, 7:10. 10.1186/1742-4690-7-10, 2839973, 20156349.
29. Hong P, Li J, Li Y. Failure to detect Xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virol J 2010, 7:224. 10.1186/1743-422X-7-224, 2945957, 20836869.
30. Hohn O, Strohschein K, Brandt AU, Seeher S, Klein S, Kurth R, Paul F, Meisel C, Scheibenbogen C, Bannert N. No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro. PLoS One 2010, 5:e15632. 10.1371/journal.pone.0015632, 3008728, 21203514.
31. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, Collier D, Wessely S, Cleare A. Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 2010, 5:e8519. 10.1371/journal.pone.0008519, 2795199, 20066031.
32. Swofford DL. PAUP. Phylogenetic analysis using parsimony (other methods). 1998, 4. Sinauer Associates, Sunderland, MA, versions.